At a glance
- Originator Abbott Laboratories
- Class Antipsychotics
- Mechanism of Action Dopamine D1 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Psychotic disorders
Most Recent Events
- 14 Dec 1994 Discontinued-Preclinical for Psychotic disorders in USA (Unknown route)